ranimustine has been researched along with Vomiting in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagawa, T; Konishi, S; Moritake, K; Nagai, H; Nagao, S; Yamasaki, T | 1 |
| Ishii, E; Kai, T; Matsuzaki, A; Ohnishi, Y; Ueda, K | 1 |
| Fujiwara, Y; Hirota, Y; Kobayashi, M; Kobayashi, T; Mitomo, Y; Ohno, R; Shirakawa, S; Tanaka, I; Yamada, H; Yamamoto, M | 1 |
3 other study(ies) available for ranimustine and Vomiting
| Article | Year |
|---|---|
[The efficacy of granisetron as a prophylactic anti-emetic agent used in conjunction with MCNU and VP16 chemotherapeutic regimens in the management of a pediatric case of hypothalamic anaplastic astrocytoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Etoposide; Glioblastoma; Granisetron; Humans; Hypothalamic Neoplasms; Interferon-beta; Male; Nausea; Nitrosourea Compounds; Vomiting | 1995 |
Successful treatment with ranimustine and carboplatin for recurrent intraocular retinoblastoma with vitreous seeding.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Child, Preschool; Cyclophosphamide; Eye Neoplasms; Fatigue; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Seeding; Nimustine; Nitrosourea Compounds; Retinoblastoma; Vision, Ocular; Vitreous Body; Vomiting | 1996 |
[Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
Topics: Administration, Oral; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Humans; Myeloproliferative Disorders; Nausea; Nitrosourea Compounds; Tablets; Vomiting | 1987 |